CClinicalTrials.gg
CompletedNCT01846013Updated Nov 1, 2019

Increasing Workplace Physical Activity in Sedentary Office Workers

An interventional study of Stand and Move in Sit-Stand Workstations, sponsored by University of Minnesota. Completed at 3 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-11-01.

Sponsored by University of Minnesota · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
260
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Purpose:

The purpose of this study is to implement and evaluate a randomized controlled trial in sitting office workers to reduce sitting time through the use of motorized and non-motorized sit/stand workstations as well as a walking intervention.

Hypotheses:

  1. Compared to the control group, total physical activity will be higher in the standing and walking intervention groups.
  2. The combined standing and walking group will have higher total physical activity than the other three groups.
  3. Compared to the control group, the fitness and health outcomes will be improved for the standing and walking groups.
02

Conditions studied

  • Sit-Stand Workstations

Keywords

  • Sit-Stand Workstations
  • Increase Workplace Physical Activity
03

In context

Lead sponsor

University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.

Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Sedentary adults who use a single computer workstation for the majority of their workday
  • Work full time (at least 35 hours per week)
  • Must have ability to safely begin a standing and/or walking protocol with no adverse side effects

Exclusion criteria

Exclusion Criteria:

  • Musculoskeletal or joint problems
  • Severe autoimmune conditions
  • Varicose veins that may cause pain
  • Women who are pregnant
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
260 participants (actual)

Study arms

  • Experimental
    Stand

    Behavioral: Stand

  • Experimental
    Move

    Behavioral: Move

  • Experimental
    Stand and Move

    Behavioral: Stand and Move

  • No intervention
    General Wellness

Interventions

  • BehavioralStand

    Stand at least half of the workday at work.

  • BehavioralMove

    Increase movement time at work. Move more by making small changes (walking meetings, take stairs, etc).

  • BehavioralStand and Move

    Increase standing time to half of workday (4h) and increase movement time at work.

06

What researchers measure

Primary outcomes

  1. Total physical activity

    Time frame: 6-months

Secondary outcomes

  1. Fasting blood glucose

    Time frame: 6-months

Other outcomes

  1. Total cholesterol

    Time frame: 6-months

  2. Body composition

    Time frame: 6-months

07

Study locations

3 sites
  • University of Minnesota
    Minneapolis, Minnesota 55454, United States
  • Fairview Energy Park
    Saint Paul, Minnesota 55108, United States
  • MN Department of Human Services
    Saint Paul, Minnesota 55164, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01846013
Lead sponsor
University of Minnesota
Collaborators
Mayo Clinic
Responsible party
Sponsor
First posted
May 3, 2013
Start date
Feb 2013
Primary completion
Mar 2014
Completion
Mar 2014
Last update
Nov 1, 2019

Study contacts

Mark A Pereira, PhD
principal investigator · University of Minnesota
Katie C Carpenter, PhD
principal investigator · University of Minnesota
Amanda R Bonikowske, MA
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion